Physician profile
Russell Wolfe
NPI 1558478586
$2,116.71
in general payments reported to CMS, 2019-2025
19 companies · $308 in 2025
The $308 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.51 · 2020: $252 · 2021: $674 · 2022: $258 · 2023: $460 · 2024: $98.50 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $866.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $447.15 | 2021-2025 | Acthar |
| Horizon Therapeutics Plc | $279.64 | 2020-2021 | |
| New World Medical,INC. | $238.29 | 2023 | |
| Bausch & Lomb Americas INC. | $193.79 | 2022-2025 | Miebo, Xiidra |
| Alcon Vision LLC | $185.49 | 2021-2025 | Argos, Clareon, Hydrus Microstent |
| Abbvie INC. | $140.30 | 2022-2025 | Alphagan P, Lumigan |
| Allergan, INC. | $133.44 | 2020-2021 | |
| Optos, INC. | $98.91 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $72.99 | 2025 | Xdemvy |
| Optovue, INC. | $65.51 | 2019 | |
| Aerie Pharmaceuticals, INC. | $60.68 | 2020-2021 | |
| Carl Zeiss Meditec USA, INC. | $51.78 | 2021 | |
| Dompe US, INC. | $32.08 | 2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $27.03 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $24.87 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18.66 | 2020 | |
| Astellas Pharma US INC | $17.30 | 2024 | Izervay |
| Oyster Point Pharma, INC. | $14.71 | 2022 | |
| Thea Pharma INC. | $14.09 | 2024 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.